IIP’s shares rose 1.1% after earnings, a roughly flat reaction. AFFO per share increased sequentially and leasing activity picked up, while the transcript also highlights continued tenant challenges and does not provide enough detail here to assess the durability of the recovery.
The stock rose 9.1% following earnings, reflecting investor approval of the significant regulatory milestone moving medical cannabis to Schedule III and solid progress in leasing activity, which eased concerns about portfolio stability and growth prospects.
Innovative Industrial Properties reported strong strategic advances in Q3 2025, highlighted by a $105 million investment in life sciences and a new $100 million credit facility, positioning the company for diversified growth.